Changes of CD68, CD163, and PD-L1 tumor expression during high-dose-rate and pulsed-dose-rate brachytherapy for cervical cancer.
Berenguer Frances MA, Linares-Galiana I, Cañas Cortés R, Marín I Borrás S, Gutiérrez Miguélez C, Najjari D, Slocker A, Bellobí C, Santacana M, Pané Foix M, Alonso MH, Navarro-Martin A, Comas Antón S, Guedea F.
Berenguer Frances MA, et al. Among authors: najjari d.
Brachytherapy. 2020 Jan-Feb;19(1):51-59. doi: 10.1016/j.brachy.2019.09.009. Epub 2019 Nov 2.
Brachytherapy. 2020.
PMID: 31690516